SCHMIEG MARTIN E. enters BRIACELL THERAPEUTICS CORP. with 575.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/1/2022ACC: 0001493152-22-020882
Director
Since Aug 2022
575.00
Baseline shares
100% direct
575.00
Direct ownership
1 position
75K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned575.00
Total
575.00 direct575.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 575.00 | Direct |
| Total | 575.00 | 575.00 direct |
Derivative Holdings2
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
25K
Shares owned
N/A
Exercise price
4.24
Expiration
—
Exercise window
—
Option (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
50K
Shares owned
N/A
Exercise price
8.47
Expiration
—
Exercise window
—
Total
Underlying
75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option (Right to Buy) Direct | Common Shares | 4.24 | — | — | 25K | N/A |
| Option (Right to Buy) Direct | Common Shares | 8.47 | — | — | 50K | N/A |
| Total | 75K | 0.00 | ||||